filtration of KOAc, the solution was treated with PPh3
without aqueous workup.
Scheme 6. PPh3 Reduction of 21 in the Presence of AcOH
The hydroxyacetates 10a and b (cis and trans) were
isolated as mixtures, whereas 11a was obtained in pure form.
Through repeated chromatography the major isomer 10a
could be isolated free of 10b. An attractive mechanism for
the formation of 7, 8 as well as 10 and 11 would feature
oxetane 13 as the key intermediate (Scheme 4). The
assignment of the cis and trans isomers of 10 is based on
independent synthesis of an authentic sample of 10a from 6
by NaBH4 reduction in MeOH at 0 °C followed by
monoacetylation of the resulting cis-1,3-diol with acetyl
chloride in CH2Cl2 in the presence of NEt3.
bisected conformation,20 we expected a similar mechanism
as with 6 with possible carbocation rearrangement involving
the cyclopropyl group. These expectations were borne out
by the following experiments. The saturated endoperoxide
21 derived from spiro[2.4]hepta-4,6-diene, prepared as
previously described,19 reacted with PPh3 in the presence of
acetic acid at room temperature to give a mixture of three
products all of which contained an acetoxy group and which
were separated from one another by silica gel chromatog-
raphy. They were identified as 22, 23a and 23b (in order of
their Rf values with 1:1 pet.ether/EtOAc, respectively) by
means of their spectral and accurate HRMS data. The
formation of the hydroxy acetates 23a and 23b is analogous
to that of 10a and 10b from 6, and is indicative of a carbocation
intermediate derived from the initial bicyclic phosphorane by
way of Ph3PdO extrusion. In particular the formation of the
1-acetoxybicyclo[3.2.01,5]heptan-2-ol (22, a single stereoisomer)
constitutes clear-cut evidence for the intervention of a carboca-
tion intermediate of the type 26, undergoing a cyclopropyl-
carbinyl-cyclobutyl rearrangement,21 followed by capture of the
cyclobutyl cation by the acetate ion.
The intermediacy of oxetane 13 and its role as a precursor
of 8 as well as 11a/b has precedent. The diphenyl analog of
13 has been prepared by Abe and Adam et al.16 and also by
Abe et al.17 (Scheme 5). The latter group observed that 16
Scheme 5. Abe et al.’s Pathway to a
6-Oxabicyclo[3.2.0]hept-1-ene (16) and its Decomposition
Products
Both 23a and 23b were stable toward AcOH under the
reaction conditions applied to 21 and did not undergo
rearrangement to 22. The mechanism outlined in Scheme 7
satisfactorily accounts for all three products.
undergoes rearrangement to form 17, the corresponding
allene aldehyde of type 8. On the other hand, with CH3CO2H
the same oxetane was reported to give mostly the cis-acetoxy
alcohol 18 with traces of the hydroxyacetates 19 and 20. In
our case, products 10a, b and 11a, b do not have to stem
from 13 and can directly be formed from 12 by loss of
Ph3PdO, followed by capture of the allyl cation 14 by the
acetate ion. We believe that 11b is a secondary product
stemming from 11a by an intramolecular acyl transfer.18
Next, we studied the triphenylphosphine reduction of the
saturated endoperoxide 21 derived from [2.4]-spiro-4,6-
heptadiene 21.19 Considering the significant stabilizing effect
of a cyclopropyl group on adjacent carbocations when the
three-membered ring and the carbocation are fixed in a
Scheme 7. Mechanism for the PPh3 Reduction of 21
The question remained whether the parent 2,3-
dioxabicyclo[2.2.1]heptyl system 3 and its [2.2.2]octyl homo-
logue 27 lacking carbocation stabilizing groups indeed undergo
PPh3 reduction by an SN2-like attack of the nucleophile (e.g.,
H2O) at the bridgehead carbon. Our results, as presented above,
(16) (a) Abe, M.; Adam, W.; Nau, W. M. J. Am. Chem. Soc. 1998,
120, 11304–11310, 15. (b) Abe, M.; Ino, S.; Nojima, M. J. Am. Chem.
Soc. 2000, 122, 6508–6509.
(17) Abe, M.; Minamoto, T.; Ino, Y.; Kawakami, T.; Nojima, M.
Tetrahedron 2002, 58, 7043–7047.
(20) de Meijere, A. Angew. Chem., Int. Ed. Engl. 1979, 18, 809–886,
and references cited therein. (b) Schleyer, P. v. R.; van Dine, G. W. J. Am.
Chem. Soc. 1966, 88, 2321–2322.
(18) (a) Yue, L.; Zhang, C.; Zhang, G. Lipids 2006, 41, 301–303. (b)
Hasegwa, H.; Akira, K.; Shinohara, Y.; Kasuya, Y.; Hashimoto, T. Biol.
Pharm. Bull. 2001, 24, 852–855. (c) Chu, L.; Davin, L. B.; Zajicek, J.;
Lewis, N. G.; Croteau, R. Phytochem. 1993, 34, 473–476.
(19) Adam, W.; Erden, I. J. Org. Chem. 1978, 43, 2737–2738.
(21) (a) Closson, W. D.; Kwiatkowski, G. T. Tetrahedron 1965, 21,
2779–2789. (b) Hanack, M.; Schneider, H.-J. Ann. 1965, 686, 8–18. (c)
Wiberg, K. B.; Hiatt, J. E.; Hseih, K. J. Am. Chem. Soc. 1970, 92, 544–
553.
3988
Org. Lett., Vol. 11, No. 17, 2009